CN110831964A - 在抗体制造期间控制粉红色形成的方法 - Google Patents

在抗体制造期间控制粉红色形成的方法 Download PDF

Info

Publication number
CN110831964A
CN110831964A CN201880031241.9A CN201880031241A CN110831964A CN 110831964 A CN110831964 A CN 110831964A CN 201880031241 A CN201880031241 A CN 201880031241A CN 110831964 A CN110831964 A CN 110831964A
Authority
CN
China
Prior art keywords
antibody
cbl
cell culture
harvest
hydrogen peroxide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201880031241.9A
Other languages
English (en)
Chinese (zh)
Inventor
杜诚
A·U·博尔万卡尔
余骏昌
谭志俊
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bristol Myers Squibb Co
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of CN110831964A publication Critical patent/CN110831964A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00Preparation of peptides or proteins
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10Cells modified by introduction of foreign genetic material
    • C12N5/12Fused cells, e.g. hybridomas
    • C12N5/16Animal cells
    • C12N5/163Animal cells one of the fusion partners being a B or a T lymphocyte
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/10Immunoglobulins specific features characterized by their source of isolation or production
    • C07K2317/14Specific host cells or culture conditions, e.g. components, pH or temperature
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00Active agents used in cell culture processes, e.g. differentation
    • C12N2501/999Small molecules not provided for elsewhere
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2511/00Cells for large scale production

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
CN201880031241.9A 2017-05-09 2018-05-08 在抗体制造期间控制粉红色形成的方法 Pending CN110831964A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201762503615P 2017-05-09 2017-05-09
US62/503,615 2017-05-09
PCT/US2018/031542 WO2018208743A1 (en) 2017-05-09 2018-05-08 Method of controlling the formation of pink color during antibody manufacturing

Publications (1)

Publication Number Publication Date
CN110831964A true CN110831964A (zh) 2020-02-21

Family

ID=62751522

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201880031241.9A Pending CN110831964A (zh) 2017-05-09 2018-05-08 在抗体制造期间控制粉红色形成的方法

Country Status (7)

Country Link
US (1) US12241107B2 (https=)
EP (1) EP3621989B1 (https=)
JP (2) JP7453788B2 (https=)
KR (1) KR102664829B1 (https=)
CN (1) CN110831964A (https=)
ES (1) ES2951287T3 (https=)
WO (1) WO2018208743A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7621284B2 (ja) 2020-01-31 2025-01-24 中外製薬株式会社 着色を抑制したポリペプチドを含む組成物の製造方法
KR20250069604A (ko) * 2022-09-15 2025-05-19 사노피 단백질 환원 민감성의 결정 방법

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006060083A1 (en) * 2004-10-22 2006-06-08 Amgen Inc. Methods for refolding polypeptides
US20090053786A1 (en) * 2007-07-09 2009-02-26 Yung-Hsiang Kao Prevention of disulfide bond reduction during recombinant production of polypeptides
US20170002393A1 (en) * 2013-12-04 2017-01-05 Immunogen, Inc. Compositions and methods for antibody production

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2689458B2 (ja) * 1988-02-09 1997-12-10 武田薬品工業株式会社 粒状ないし粉末状のビタミンb▲下1▼▲下2▼類含有組成物
JP2734709B2 (ja) * 1990-01-05 1998-04-02 東レ株式会社 インクジェット染色用布帛およびそれを用いてなるインクジェット染色法
SE525083C2 (sv) * 2003-04-23 2004-11-23 Kemira Kemi Ab Sätt att behandla rötslam
EP1971488A2 (en) * 2005-12-05 2008-09-24 Lifeline Cell Technology Cell culture medium container assembly
CA2765220A1 (en) 2009-07-14 2011-01-20 Biogen Idec Ma Inc. Methods for inhibiting yellow color and peroxide formation in a composition

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006060083A1 (en) * 2004-10-22 2006-06-08 Amgen Inc. Methods for refolding polypeptides
US20090053786A1 (en) * 2007-07-09 2009-02-26 Yung-Hsiang Kao Prevention of disulfide bond reduction during recombinant production of polypeptides
US20170002393A1 (en) * 2013-12-04 2017-01-05 Immunogen, Inc. Compositions and methods for antibody production

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
GAYLE E DERFUS等: "Red colored IgG4 caused by vitamin B12 from cell culture media combined with disulfide reduction at harvest", 《MABS》 *
GAYLE E DERFUS等: "Red colored IgG4 caused by vitamin B12 from cell culture media combined with disulfide reduction at harvest", 《MABS》, vol. 6, no. 3, 19 February 2014 (2014-02-19), pages 679 - 688, XP002784132 *
KENNETH M PRENTICE等: "Hydroxocobalamin association during cell culture results in pink therapeutic proteins", 《MABS》 *
KENNETH M PRENTICE等: "Hydroxocobalamin association during cell culture results in pink therapeutic proteins", 《MABS》, vol. 5, no. 6, 26 July 2013 (2013-07-26), pages 974 - 981, XP002784134 *
M. V. SIDOROVA等: "The Use of Hydrogen Peroxide for Closing Disulfide Bridges in Peptides", 《RUSSIAN JOURNAL OF BIOORGANIC CHEMISTRY》 *
M. V. SIDOROVA等: "The Use of Hydrogen Peroxide for Closing Disulfide Bridges in Peptides", 《RUSSIAN JOURNAL OF BIOORGANIC CHEMISTRY》, vol. 30, no. 2, 31 March 2004 (2004-03-31), pages 101 - 110, XP002605163 *

Also Published As

Publication number Publication date
ES2951287T3 (es) 2023-10-19
WO2018208743A9 (en) 2019-12-05
EP3621989B1 (en) 2023-06-28
US12241107B2 (en) 2025-03-04
WO2018208743A1 (en) 2018-11-15
JP2023182593A (ja) 2023-12-26
JP2020519265A (ja) 2020-07-02
JP7453788B2 (ja) 2024-03-21
EP3621989A1 (en) 2020-03-18
KR102664829B1 (ko) 2024-05-09
US20230103511A1 (en) 2023-04-06
KR20200004355A (ko) 2020-01-13

Similar Documents

Publication Publication Date Title
Sharma et al. Synthesis and characterization of a peptide identified as a functional element in αA-crystallin
CA3129193C (en) Anti-vegf protein compositions and methods for producing the same
JP2023182593A (ja) 抗体製造の間のピンク色の形成を制御する方法
Wagner et al. Determination of size variants by CE-SDS for approved therapeutic antibodies: Key implications of subclasses and light chain specificities
Wang et al. Investigation of antibody disulfide reduction and re-oxidation and impact to biological activities
JP2021534151A (ja) 下流クロマトグラフィーにおける再酸化によるタンパク質断片化制御戦略
Du et al. Vitamin B12 association with mAbs: Mechanism and potential mitigation strategies
Pan et al. Membrane protein structural insights from chemical labeling and mass spectrometry
Watson et al. Replacement or exclusion of the B-branch bacteriopheophytin in the purple bacterial reaction centre: the HB cofactor is not required for assembly or core function of the Rhodobacter sphaeroides complex
Sudharshan et al. pH-induced domain interaction and conformational transitions of lipoxygenase-1
Yamamoto et al. Evidence for ATP-dependent structural rearrangement of nuclease catalytic site in DNA mismatch repair endonuclease MutL
Muslinkina et al. Structural factors enabling successful GFP-like proteins with alanine as the third chromophore-forming residue
Bitterwolf Photolysis of [Ru (bipy) 2 (NO) Cl](PF6) 2 in frozen ionic glass matrices. Evidence for nitrosyl linkage isomerism and NO-loss in a physiologically relevant nitric oxide source
deBoer et al. Tyrosine nitration in peptides by peroxynitrite generated in situ in a light-controlled platform: Effects of pH and thiols
WO2008021211A3 (en) Compositions and methods for modulating apoptosis in cells over-expressing bcl-2 family member proteins
AU2015294389A1 (en) Methods of conjugating an agent to a thiol moiety in a protein that contains at least one trisulfide bond
Jha et al. Mutation of Phe413 to Tyr in catalase KatE from Escherichia coli leads to side chain damage and main chain cleavage
Tan Disulfide Bond Reduction And Reoxidation Of Monoclonal Antibodies In Biologics Therapeutics Processes-Kinetics Understanding And Applications
Vahrenkamp Investigating the functional conservation of BRCA1/BARD1 in Caenorhabditis elegans
Bommana Degradation of therapeutic proteins: Screening methods and identification of epimerized amino acids and local conformational changes in light exposed proteins
Ho Gamma-Irradiation of Myoglobins
Theßeling Structure of the ubiquinol: oxygen cytochrome bd-I oxidoreductase from Escherichia coli
Seefeldt High pressure refolding of protein aggregates: efficacy and thermodynamics
BR122024024332A2 (pt) Método para produzir aflibercepte
Lee Pigment stoichiometry of photosynthetic multiple-protein complexes from dark and high-light treated plants

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination